Quick Answer
Design Therapeutics, Inc. reported Revenue (ASC 606) of $226.0 thousand for fiscal year 2020.
Design Therapeutics, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2020 | $226.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $20.0K | — | -35.5% |
| June 30, 2020 | $31.0K | — | -78.2% |
| March 31, 2020 | $142.0K | — | — |
- The most recent figure is from Design Therapeutics, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 10, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: